Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹-38 Cr₹389 Cr₹19 Cr₹255 Cr₹14 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS is ₹-38 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹-38 Cr
Mar2024₹389 Cr
Mar2023₹19 Cr
Mar2022₹255 Cr
Mar2021₹14 Cr

How is Net Cash Inflow / Outflow of GLENMARK PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹-38 Cr
Negative
Mar2024 ₹389 Cr
1,902.17
Mar2023 ₹19 Cr
-92.37
Mar2022 ₹255 Cr
1,695.19
Mar2021 ₹14 Cr -

Compare Net Cash Inflow / Outflow of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,793.1 Cr 3.5% 0.6% 10.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,530.0 Cr -0.4% 0.9% 19.6% Stock Analytics
DIVIS LABORATORIES ₹219,675.0 Cr -1.2% 21.1% 29.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,970.0 Cr -2.3% 0.3% 34.8% Stock Analytics
CIPLA ₹117,947.0 Cr 0.7% 1.5% -2% Stock Analytics
DR REDDYS LABORATORIES ₹96,601.2 Cr -0.3% -7.1% -3.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.5%

0.6%

10.7%

SENSEX

-0.1%

2.4%

-3.3%


You may also like the below Video Courses